nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.11.2007 | Original Article

Comparison of ^99mTc-annexin A5 with ¹⁸F-FDG for the detection of atherosclerosis in ApoE−/− mice

verfasst von: Yan Zhao, Yuji Kuge, Songji Zhao, Koichi Morita, Masayuki Inubushi, H. William Strauss, Francis G. Blankenberg, Nagara Tamaki

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

^99mTc-annexin A5, a marker of ongoing apoptosis, and ¹⁸F-FDG, a marker of the increased metabolism of inflammatory cells, are supposed to be useful in the detection of metabolically active atheroma. This study reports a comparison of the intralesional distribution of these tracers in relation to lesion development in ApoE−/− mice.

Methods

Male ApoE−/− mice (n = 12–14/group) were maintained on a Western-type diet after the age of 5 weeks. At 25 weeks, ^99mTc-annexin A5 or ¹⁸F-FDG was injected and the aortas were harvested for autoradiography (ARG) and Oil Red O staining. Regional radioactivity accumulation was compared in relation to the Oil Red O staining score (ranging from 0 to 3, a semiquantitative parameter for evaluating lesion development).

Results

Both ^99mTc-annexin A5 and ¹⁸F-FDG showed preferential uptake into atherosclerotic lesions, with higher uptake levels for ¹⁸F-FDG (mean, 56.07 %ID×kg/m²) than for ^99mTc-annexin A5 (mean, 10.38 %ID×kg/m²). The regional uptake levels of each tracer correlated with the Oil Red O staining score (r = 0.65, p < 0.05 for ^99mTc-annexin A5; r = 0.56, p < 0.05 for ¹⁸F-FDG). The uptake ratios of advanced lesions (score >0.5) to early lesions (score <0.5) were significantly higher for ^99mTc-annexin A5 than for ¹⁸F-FDG (f = 4.73, p = 0.03).

Conclusion

Both ^99mTc-annexin A5 and ¹⁸F-FDG accumulate in atherosclerotic lesions and correlate with the severity of each lesion. The higher absolute uptake levels of ¹⁸F-FDG may be advantageous for lesion detection, whereas the preferential uptake of ^99mTc-annexin A5 in advanced lesions may be a useful indicator of late-stage lesions or vulnerable plaque transformation.

Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 2003;16:267–72.PubMedCrossRef

Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262–75.PubMed

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801–9.PubMedCrossRef

Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001;358:1533–8.PubMedCrossRef

John RD, James FR, Tim DF, Peter LW. Targeting the vulnerable plaque: the evolving role of nuclear imaging. J Nucl Med 2005;12:234–46.

Nissen SE, Yock P. Intravascular ultrasound novel pathophysiological insights and current clinical applications. Circulation 2001;103:604–16.PubMed

Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640–5.PubMedCrossRef

Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 1999;99:1965–71.PubMed

Waki H, Masuyama H, Mori H, Maeda T, Kitade K, Moriyasu K, et al. Ultrasonic tissue characterization of the atherosclerotic carotid artery: histological correlates or carotid integrated backscatter. Circ J 2003;67:1013–6.PubMedCrossRef

10.

Schroeder S, Kopp AF, Baumbach A, Meisner C, Kuettner A, Georg C, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol 2001;37:1430–5.PubMedCrossRef

11.

Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62–7.PubMedCrossRef

12.

Trivedi RA, King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004;35:1631–5.PubMedCrossRef

13.

Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998;95:6349–54.PubMedCrossRef

14.

Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115–26.PubMedCrossRef

15.

Van der Wal AC, Becker AE, Van der Loss CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation 1994;89:36–44.PubMed

16.

Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Am J Pathol 1995;147:251–66.PubMed

17.

Lendon CI, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991;87:87–90.PubMedCrossRef

18.

Strauss HW, Grewal RK, Pandit-Taskar N. Molecular imaging in nuclear cardiology. Semin Nucl Med 2004;34:47–55.PubMedCrossRef

19.

Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294–301.PubMedCrossRef

20.

Lederman RJ, Raylman RR, Fisher SJ, Kison PV, San H, Nabel EG. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 2001;22:747–53.PubMedCrossRef

21.

Rudd JHF, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N. Imaging atherosclerotic plaque inflammation with [¹⁸F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708–11.PubMedCrossRef

22.

Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H. ¹⁸F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245–50.PubMed

23.

Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003;108:3134–9.PubMedCrossRef

24.

Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343–53.PubMedCrossRef

25.

Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468–71.PubMedCrossRef

26.

Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001;154:399–406.PubMedCrossRef

27.

Williams H, Johnson JL, Carson KGS, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in the brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2002;22:788–92.PubMedCrossRef

28.

Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005;111:1422–30.PubMedCrossRef

29.

Coleman R, Hayek T, Keidar S, Aviram M. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochem 2006;108:415–24.PubMedCrossRef

30.

Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873–80.PubMed

31.

Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW. Development and characterization of annexin V mutants with endogenous chelation sites for ^99mTc. Bioconjug Chem 2000;11:918–25.PubMedCrossRef

32.

Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, et al. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with ^99mTc-annexin V. J Nucl Med 2003;44:92–7.PubMed

33.

Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma. I. Are inflammatory cells important? J Nucl Med 1995;36:1854–61.PubMed

34.

Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, et al. Biologic correlates of intratumoral heterogeneity in ¹⁸F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:794–9.PubMed

35.

Johnson LL, Schofield L, Donahay T, Narula N, Narula J. ^99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005;46:1186–93.PubMed

36.

Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350:1472–3.PubMedCrossRef

37.

Strauss HW, Mari C, Patt BE, Ghazarossian V. Intravascular radiation detectors for the detection of vulnerable atheroma. J Am Coll Cardiol 2006;47(8 Suppl):C97–100.PubMedCrossRef

38.

Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 2006;47:1497–505.PubMed

39.

Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, et al. Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 2004;15:373–9.PubMedCrossRef

40.

Smith-Jones PM, Afroze A, Zanzonico P, Tait J, Larson SM, Strauss HW. ⁶⁸Ga labeling of annexin-V: comparison to ^99mTc-annexin-V and ⁶⁷Ga-annexin. J Nucl Med 2003;44(5 Suppl):49P–50P.

41.

Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med 2006;6:3.PubMedCrossRef

42.

Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo ¹⁸F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818–24.PubMedCrossRef

43.

Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atehrosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000;20:2587–92.PubMed

44.

Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apoliporotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002 282:E207–14.PubMed

45.

Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 2001;104:203–8.PubMed

46.

Qin G, Zhang Y, Cao W, An R, Gao Z, Li G, et al. Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides. Eur J Nucl Med Mol Imaging 2005;32:6–14.PubMedCrossRef

47.

Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, et al. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005;46:2051–6.PubMed

48.

Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, et al. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res 2006;71:586–95.PubMedCrossRef

49.

Mazzolai L, Duchosal MA, Korber M, Bouzourene K, Aubert JF, Hao H, et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE−/− mice. Hypertension 2004;44:277–82.PubMedCrossRef

Titel: Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE−/− mice
verfasst von: Yan Zhao
Yuji Kuge
Songji Zhao
Koichi Morita
Masayuki Inubushi
H. William Strauss
Francis G. Blankenberg
Nagara Tamaki
Publikationsdatum: 01.11.2007
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0433-2

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2007

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

EANM Marie Curie training grant project report PET–CT in oncology imaging

Diffuse venous malformation within the left side of the body visualized by Tc-99m-labeled RBC scan

Is the clinical staging system a good choice in the staging of vulvar malignancies?

G.J.R. Cook, M.N. Maisey, K.E. Britton and V. Chengazi, (eds.): Clinical nuclear medicine, 4th edition.

In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans